About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 201857, 9 pages
http://dx.doi.org/10.1155/2013/201857
Research Article

The Association between Yang-Deficient Constitution and Clinical Outcome of Highly Active Antiretroviral Therapy on People Living with HIV

1Department of Infectious Diseases, Guangzhou 8th People’s Hospital, 627 Dongfeng Dong Road, Guangzhou 510060, China
2Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong

Received 5 October 2013; Revised 11 December 2013; Accepted 11 December 2013

Academic Editor: Youn Chul Kim

Copyright © 2013 Yuwen Cen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Zhang, Z. Dou, Y. Ma et al., “Five-year outcomes of the China National Free Antiretroviral Treatment Program,” Annals of Internal Medicine, vol. 151, no. 4, pp. 241–251, 2009. View at Scopus
  2. K. Joshi, Y. Ghodke, and P. Shintre, “Traditional medicine and genomics,” Journal of Ayurveda and Integrative Medicine, vol. 1, no. 1, pp. 26–32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Chen, F. Lv, J. Gao et al., “HLA class II polymorphisms associated with the physiologic characteristics defined by traditional Chinese medicine: linking modern genetics with an ancient medicine,” Journal of Alternative and Complementary Medicine, vol. 13, no. 2, pp. 231–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Wang, “Classification and diagnosis basis of nine basic constitutions in Chinese medicine,” Journal of Beijing University of Traditional Chinese Medicine, vol. 28, no. 4, pp. 1–8, 2005.
  5. J. Wang, Y. Li, C. Ni, H. Zhang, L. Li, and Q. Wang, “Cognition research and constitutional classification in chinese medicine,” American Journal of Chinese Medicine, vol. 39, no. 4, pp. 651–660, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. Q. Wang and S. Yao, “Molecular basis for cold-intolerant yang-deficient constitution of traditional chinese medicine,” American Journal of Chinese Medicine, vol. 36, no. 5, pp. 827–834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Wu, Y. Zhu, N. Wu, J. Di, and Y. Wang, “The relationshio between diet habits and constitution type in the general population 8448 adults cases from nine provinces or municipalities of China,” Chinese Journal of Health Management, vol. 6, pp. 64–67, 2012.
  8. F. Tang, Y. Zhu, and N. Wu, “Study on the college students’ psychological characteristics of personality of the nine constitutions in traditional Chinese medicine,” Chinese Journal of Behavioral Medical Science, vol. 21, pp. 63–65, 2012.
  9. Y.-B. Zhu, Q. Wang, K.-F. Chen, Y.-E. Wu, W.-L. Hong, and L. Liu, “Stratified analysis of the relationship between traditional Chinese medicine constitutional types and health status in the general population based on data of 8 448 cases,” Journal of Chinese Integrative Medicine, vol. 9, no. 4, pp. 382–389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-B. Zhu, Q. Wang, C.-Y. Wu et al., “Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity,” Journal of Chinese Integrative Medicine, vol. 8, no. 11, pp. 1023–1028, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-B. Zhu, Q. Wang, Q.-W. Deng, J. Cai, X.-H. Song, and X. Yan, “Relationships between constitutional types of traditional Chinese medicine and hypertension,” Journal of Chinese Integrative Medicine, vol. 8, no. 1, pp. 40–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Makino, K. Kato, and H. Mizukami, “Processed aconite root prevents cold-stress-induced hypothermia and immuno-suppression in mice,” Biological and Pharmaceutical Bulletin, vol. 32, no. 10, pp. 1741–1748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Park, Y. J. Kang, M. K. Park et al., “Enantiomers of higenamine inhibit LPS-induced iNOS in a macrophage cell line and improve the survival of mice with experimental endotoxemia,” International Immunopharmacology, vol. 6, no. 2, pp. 226–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. J. Kang, Y. S. Lee, G. W. Lee et al., “Inhibition of activation of nuclear factor κB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root,” Journal of Pharmacology and Experimental Therapeutics, vol. 291, no. 1, pp. 314–320, 1999. View at Scopus
  15. S. Zheng, H.-J. Wu, S.-P. Yu, et al., “Shenfu injection () suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure,” Chinese Journal of Integrative Medicine, 2013. View at Publisher · View at Google Scholar
  16. X. Hou, C. Li, W. Gu, Z. Guo, W. Yin, and D. Zhang, “Effect of Shenfu on inflammatory cytokine release and brain edema after prolonged cardiac arrest in the swine,” The American Journal of Emergency Medicine, vol. 31, pp. 1159–1164, 2013.
  17. T. Chen, M. Cheng, Z. Yuan, S. Zhou, and Z. Yu, “Protective role of Shenfu on ischemia-reperfusion injury of rat liver grafts,” Transplantation Proceedings, vol. 44, no. 4, pp. 978–981, 2012. View at Publisher · View at Google Scholar
  18. Q. Wang, Y.-B. Zhu, H.-S. Xue, and S. Li, “Primary compiling of Constitution in Chinese Medicine Questionnaire,” Chinese Journal of Clinical Rehabilitation, vol. 10, no. 3, pp. 12–14, 2006. View at Scopus
  19. Y.-B. Zhu, Q. Wang, H.-S. Xue, and Q. Orikasa, “Preliminary assessment on performance of Constitution in Chinese Medicine Questionnaire,” Chinese Journal of Clinical Rehabilitation, vol. 10, no. 3, pp. 15–17, 2006. View at Scopus
  20. Y. Zhu, Q. Wang, and H. Orikasa, “Evaluation on reliability and validity of the constitution in Chinese medicine,” Chinese Journal of Behavioral Medical Science, vol. 16, pp. 651–655, 2007.
  21. M. M. Breuniq, H.-P. Kriegel, R. T. Ng, and J. Sander, “LOF: identifying density-based local outliers,” in Proceeding of the ACM SIGMOD International Conference on Management of Data, vol. 29, pp. 93–104, Dallas, Tex, USA, 2000. View at Scopus
  22. F. Zhang, Z. Dou, Y. Ma et al., “Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study,” The Lancet Infectious Diseases, vol. 11, no. 7, pp. 516–524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Gupta, G. Nadkarni, W.-T. Yang et al., “Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis,” PLoS ONE, vol. 6, no. 12, Article ID e28691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Zhou, G. F. Kominski, H.-Z. Qian et al., “Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs,” BMC Medicine, vol. 9, article 6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Shan, J. Sun, A. Yakusik, et al., “Total HIV/AIDS expenditures in Dehong Prefecture, Yunnan province in 2010: the first systematic evaluation of both health and non-health related HIV/AIDS expenditures in China,” PLoS ONE, vol. 8, Article ID e68006, 2013.
  26. J. D. Neaton, J. Neuhaus, and S. Emery, “Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010,” Current Opinion in HIV and AIDS, vol. 5, no. 6, pp. 480–490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Tang and S. Li, “Studies on insulin resistance, sexual hormone and β2-microglobulin levels in essential hypertension patients with spleen and kidney yang deficiency,” Journal of Guangzhou University of Traditional Chinese Medicine, vol. 25, no. 3, pp. 193–195, 2008.
  28. T. Rampp, L. Tan, L. Zhang et al., “Menopause in German and Chinese women—an analysis of symptoms, TCM-diagnosis and hormone status,” Chinese Journal of Integrative Medicine, vol. 14, no. 3, pp. 194–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Jones and M. Núñez, “Liver toxicity of antiretroviral drugs,” Seminars in Liver Disease, vol. 32, pp. 167–176, 2012.
  30. L. Gao, F. Zhou, X. Li, and Q. Jin, “HIV/TB co-infection in mainland China: a meta-analysis,” PLoS ONE, vol. 5, no. 5, Article ID e10736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. W. W. Yew and C. C. Leung, “Antituberculosis drugs and hepatotoxicity,” Respirology, vol. 11, no. 6, pp. 699–707, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. M. Estrella, D. M. Fine, and M. G. Atta, “Recent developments in HIV-related kidney disease,” HIV Therapy, vol. 4, no. 5, pp. 589–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. D. Cooper and M. Tonelli, “Renal disease associated with antiretroviral therapy in the treatment of HIV,” Nephron—Clinical Practice, vol. 118, no. 3, pp. c262–c268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. T. N. Kakuda, “Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity,” Clinical Therapeutics, vol. 22, no. 6, pp. 685–708, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Scorrano, “Keeping mitochondria in shape: a matter of life and death,” European Journal of Clinical Investigation, vol. 43, pp. 886–893, 2013.
  36. X. Huang, Q. Chen, G. Yang, et al., “Metabolic profiling study of yang deficiency syndrome in hepatocellular carcinoma by h1 NMR and pattern recognition,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 843048, 6 pages, 2012. View at Publisher · View at Google Scholar